Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00953095 · ClinicalTrials.gov registry record · NA

Social and Communication Outcomes for Young Children With Autism

A NA study, sponsored by Health Resources and Services Administration (HRSA).

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT00953095 is a NA study that has completed, run by Health Resources and Services Administration (HRSA). The registered enrollment target is 112 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00953095, a NA study, has completed, sponsored by Health Resources and Services Administration (HRSA).

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

The goal of this project is to test an intervention program for caregivers and their young children with autism that is focused on improving social communication. This study specifically targets underserved populations, specifically children from low SES and racial/ethnic minority families. Participants will include 40 children (aged 24 months to 60 months) and their caregivers who will be randomized (as if by flipping a coin) to one of the two treatments: Parent education sessions for two hours a week for 12 weeks or parent-child intervention sessions with the child for one hour, twice a week for 12 weeks. Young children with autism have difficulty with engaging in joint attention with others (e.g. pointing, showing. Joint attention skills are important to later development of language. Therefore, targeting this problem in young children may result in better language outcomes for these children. In order to examine the effects of the interventions, all participants will be complete cognitive, language, communication and play-based assessments prior to treatment, at the end of the first 12 weeks of the intervention, and post-treatment immediately following the intervention (approximately 2.5 to 3 hours each).

Interventions

  • BEHAVIORAL Joint Attention Intervention

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2009-04
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT00953095

The ClinicalTrials.gov registry entry for NCT00953095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Health Resources and Services Administration (HRSA), which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Joint Attention Intervention is the first listed.

NCT00953095 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00953095 about?

NCT00953095 is a clinical study titled "Social and Communication Outcomes for Young Children With Autism". The goal of this project is to test an intervention program for caregivers and their young children with autism that is focused on improving social communication. This study specifically targets underserved populations, specifically children from low SES and racial/ethnic minority families. Particip...

What is the current status of trial NCT00953095?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2009-04. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00953095?

The interventions under investigation include: Joint Attention Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00953095?

This trial is sponsored by Health Resources and Services Administration (HRSA), which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.